EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

STING inhibition enables efficient plasmid-based gene expression in primary vascular cells: A simple and cost-effective transfection protocol

Shuai Yuan iD, Adam C Straub

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0303472 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS ONE, 2024. Verfasst von Shuai Yuan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, United States of America. Hauptthemen laut MEDLINE: Plasmids, Transfection, Membrane Proteins, Endothelial Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plasmid transfection in cells is widely employed to express exogenous proteins, offering valuable mechanistic insight into their function(s). However, plasmid transfection efficiency in primary vascular endothelial cells (ECs) and smooth muscle cells (SMCs) is restricted with lipid-based transfection reagents such as Lipofectamine. The STING pathway, activated by foreign DNA in the cytosol, prevents foreign gene expression and induces DNA degradation. To address this, we explored the potential of STING inhibitors on the impact of plasmid expression in primary ECs and SMCs. Primary human aortic endothelial cells (HAECs) were transfected with a bicistronic plasmid expressing cytochrome b5 reductase 4 (CYB5R4) and enhanced green fluorescent protein (EGFP) using Lipofectamine 3000. Two STING inhibitors, MRT67307 and BX795, were added during transfection and overnight post-transfection. As a result, MRT67307 significantly enhanced CYB5R4 and EGFP expression, even 24 hours after its removal. In comparison, MRT67307 pretreatment did not affect transfection, suggesting the inhibitor’s effect was readily reversible. The phosphorylation of endothelial nitric oxide synthase (eNOS) at Serine 1177 (S1177) by vascular endothelial growth factor is essential for endothelial proliferation, migration, and survival. Using the same protocol, we transfected wild-type and phosphorylation-incapable mutant (S1177A) eNOS in HAECs. Both forms of eNOS localized on the plasma membrane, but only the wild-type eNOS was phosphorylated by vascular endothelial growth factor treatment, indicating normal functionality of overexpressed proteins. MRT67307 and BX795 also improved plasmid expression in human and rat aortic SMCs. In conclusion, this study presents a modification enabling efficient plasmid transfection in primary vascular ECs and SMCs, offering a favorable approach to studying protein function(s) in these cell types, with potential implications for other primary cell types that are challenging to transfect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlasmidsTransfectionMembrane ProteinsEndothelial CellsHumansMyocytes, Smooth MuscleGreen Fluorescent ProteinsAnimalsNitric Oxide Synthase Type IIICells, CulturedPhosphorylationRatsGene ExpressionMuscle, Smooth, VascularSTING Protein

Substanzen

Membrane ProteinsGreen Fluorescent ProteinsNitric Oxide Synthase Type IIISTING1 protein, humanSTING Proteinenhanced green fluorescent protein

Autor:innen und Institutionen

  • Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, United States of America.
  • Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
  • Center for Microvascular Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

ORCID-Profile: Shuai Yuan

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • American Heart Association

Zitieren

APA

Yuan, S., & Straub, A. C. (2024). STING inhibition enables efficient plasmid-based gene expression in primary vascular cells: A simple and cost-effective transfection protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0303472

Vancouver

Yuan S, Straub AC. STING inhibition enables efficient plasmid-based gene expression in primary vascular cells: A simple and cost-effective transfection protocol. PLOS ONE. 2024. doi:10.1371/journal.pone.0303472

BibTeX
@article{Yuan2024,
  author = {Yuan, Shuai and Straub, Adam C},
  title = {STING inhibition enables efficient plasmid-based gene expression in primary vascular cells: A simple and cost-effective transfection protocol},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0303472}
}
Kostenlos starten →